Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-37210

Single-particle
3.17 Å
EMD-37210 Deposition: 17/08/2023
Map released: 19/06/2024
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-37210

Prefusion RSV F Bound to Lonafarnib and D25 Fab

EMD-37210

Single-particle
3.17 Å
EMD-37210 Deposition: 17/08/2023
Map released: 19/06/2024
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Human respiratory syncytial virus A (strain A2), Enterobacteria phage T4
Sample: Prefusion RSV F Bound to Lonafarnib and D25 Fab
Fitted models: 8kg5

Deposition Authors: Yang Q, Xue B, Liu F , Peng W, Chen X
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein.
Yang Q, Xue B, Liu F , Lu Y, Tang J, Yan M, Wu Q, Chen R, Zhou A, Liu L, Liu J, Qu C, Wu Q, Fu M, Zhong J, Dong J, Chen S, Wang F , Zhou Y, Zheng J, Peng W, Shang J , Chen X
(2024) Signal Transduct Target Ther , 9 , 144 - 144
PUBMED: 38853183
DOI: doi:10.1038/s41392-024-01858-5
ISSN: 2059-3635